| AJCC | American Joint Committee on Cancer |
| BASQ | Basal-squamous-like |
| CK | Cytokeratin |
| DEG | Differential expression gene |
| DN | Double-negative |
| DP | Double-positive |
| EMT | Epithelial-mesenchymal transition |
| FFPE | Formalin-fixed paraffin-embedded |
| GO | Gene ontology |
| GSEA | Gene set enrichment analysis |
| IHC | Immunohistochemistry |
| IL-6 | Interleukin-6 |
| IPA | Ingenuity Pathway Analysis |
| IRB | Institutional Review Board |
| ISUP | International Society of Urologic Pathologists |
| JAK | Janus kinase |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| MIBC | Muscle invasive urinary bladder cancer |
| miR | MicroRNA |
| NF-κB | Nuclear factor-κB |
| NGS | Next-generation sequencing |
| OS | Overall survival |
| PD-1 | Programmed cell death-1 |
| PD-L1 | Programmed cell death-ligand 1 |
| PFS | Progression-free survival |
| SP | Single-positive |
| STAT3 | Signal transducer and activator of transcription 3 |
| TMA | Tissue microarray |
| TNF | Tumor necrosis factor |
| UB UC | Urinary bladder urothelial carcinoma |
| WHO | World Health Organization |